Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease

Kidney and Blood Pressure Research

Volumn 32, Issue 6, 2010, Pages 405-410

  Pietrzak Nowacka, Maria ^a,c   Safranow, Krzysztof ^a   Byra, Elbieta ^a   Bińczak Kuleta, Agnieszka ^b   Ciechanowicz, Andrzej ^b   Ciechanowski, Kazimierz ^a  

^a Clinical Hospital No 2   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Samodzielna Pracownia Farmakoterapii Dermatologicznej al Powsta ców Wlkp 72   (Poland)

Author keywords

Autosomal dominant polycystic kidney disease; Diabetes; Metabolic syndrome; Oral glucose tolerance test

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LABORATORY TEST; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; DIABETES COMPLICATIONS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; WAIST-HIP RATIO;

EID: 70450171212     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000260042     Document Type: Article

References (31)

1. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983;2:630-639.
2. Bogdanova N, Markoff A, Horst J: Autosomal dominant polycystic kidney disease-clinical and genetic aspects. Kidney Blood Press Res 2002;25:265-283.
3. Driscoll JA, Bhalla S, Liapis H, Ibricevic A, Brody SL: Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest 2008;133:1181-1188.
4. Ecder T, Schrier RW: Hypertension in autosomal-dominant polycystic kidney disease; early occurrence and unique aspects. J Am Soc Nephrol 2001; 12:194-200.
5. De Almeida EA, de Oliveira EI, Lopes JA, Almeida AG, Lopes MG, Prata MM: Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease. Rev Port Cardiol 2007;26:235-243.
6. Kelleher CL, McFann KK, Johnson AM, Schrier RW: Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general US population. Am J Hypertens 2004;17:1029-1034.
7. Ducloux D, Motte G, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM: Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 1999;14:1244-1246.
8. de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ: Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 2005; 67: 714-720.
9. Hamer RA, Chow CL. Ong AC, McKane WS: Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007;83:36-40.
10. Gentil MA, Luna E, Rodriguez-Algarra G, Osuna A, Gonzales-Molina M, Mazuecos A, Cubero JJ, del Castillo D: Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17: 887-891.
11. Pietrzak-Nowacka M, Safranow K, Różański J, Dȩbska-Ślizień A, Domański L, Dziewanowski K, Głyga M, Jankowska M, Noceń M, Pabisiak K, Rutkowski B, Wiśniewska M, Ciechanowski K: Autosomal dominant polycystic kidney disease is not the risk factor for post-transplant diabetes mellitus: matched-pair design multicenter study. Arch Med Res 2008;39:312-319.
12. Pietrzak-Nowacka M, Różański J, Safranow K, Kȩdzierska K, Dutkiewicz G, Ciechanowski K: Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus. Arch Med Res 2006;37:360-364.
13. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
14. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
15. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: executive summary of third report of the National Cholesterol Education Program NCEP Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel-ATP III). JAMA 2001;285:2486-2497.
16. The IDF (International Diabetes Federation) consensus worldwide definition of the metabolic syndrome. Berlin, 2005, www.idf.org
17. Vareesangthip K, Tong P, Wilkinson R, Thomas TH: Insulin resistance in adult polycystic kidney disease. Kidney Int 1997; 52: 503-508.
18. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-827.
19. WHO: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, WHO, 1999.
20. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
21. Abbasi F, Reaven GM: Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002;51:235-237.
22. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
24. Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995;5:2048-2056.
25. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713.
26. Zdrojewski T, Bandosz P, Szpakowski P, Konarski R, Jakubowski Z, Manikowski A, Wołkiewicz E, Łysiak-Szydłowska W, Bau-tembach S, Wyrzykowski B: Prevalence of the main cardiovascular disease risk factors in Poland. Results of the NATPOL PLUS study (in Polish). Kardiol Pol 2004;61:5-26.
27. Thomas L: Blood glucose; in Thomas L (ed): Clinical Laboratory Diagnostics Use and Assessment of Clinical Laboratory Results. Frankfurt am Main, TH-Books Verlagsge-sellschaft GmbH, 1998, pp 131-137.
28. Wyrzykowski B, Zdrojewski T, Sygnowska E, Biela U, Drygas W, Tykarski A, Tendera M, Broda G: Epidemiology of the metabolic syndrome in Poland. Results of the National Health Survey in Poland-WOBASZ study (in Polish). Kardiol Pol 2005;63(suppl 4):S641-S644.
29. Locatelli F, Pozzoni P, Del Vecchio L: Renal manifestations in the metabolic syndrome. J Am Soc Nephrol 2006;17:S81-S85.
30. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic disease in U.S. adults. Ann Intern Med 2004; 140:167-174.
31. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997;51: 1908-1919.